D-0515-2019 Class III Terminated

Recalled by Akorn Inc — Lake Forest, IL

FDA drug recall D-0515-2019 was initiated by Akorn Inc on Jan 25, 2019 and is designated Class III. Reason for recall: Failed Stability Specification; out of specification (OOS) results for a preservative at 9 month stability study. The recall status is terminated (terminated Nov 3, 2020). Affected quantity: a) 4896 tubes; b) 5064 tubes.

Recall details

Product Type
Drugs
Report Date
Feb 27, 2019
Initiation Date
Jan 25, 2019
Termination Date
Nov 3, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 4896 tubes; b) 5064 tubes

Product description

Clobetasol Propionate Emollient Cream 0.05%, a) 30 gram (NDC 50383-270-30) and b) 60 gram (NDC 50383-270-60) tubes, Rx only. Manufacturer: Akorn Inc. 369 Bayview Ave., Amityville, NY 117701.

Reason for recall

Failed Stability Specification; out of specification (OOS) results for a preservative at 9 month stability study.

Distribution pattern

Nationwide, including Puerto Rico.

Code information

a) 357052, exp 4/19/19 b) 356892, exp 4/16/19 and 356927, exp 4/15/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0515-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0515-2019. Report a data issue: hello@regdatalab.com.